Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US8256935003

Price
5.23 USD
Market cap
24.92 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Shuttle Pharmaceuticals Holdings, Inc. financials

Fiscal year2025
Operating income-11.92 m USD
EBIT-11.72 m USD
Net income-11.72 m USD
Diluted EPS – continuing operations-7.16 USD

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.